Table 3. Clinical characteristics of controls and chronic kidney disease (CKD) subjects.
| Controls | CKD subjects | |
|---|---|---|
| Number of subjects | 7 | 7 |
| Age (years) | 50±3 | 55±2 |
| Gender (M/F) | 4/3 | 4/3 |
| BMI (kg/m2) | 24±2 | 23±1 |
| FFM (kg) | 51±2 | 49±3 |
| Fat mass (kg) | 24±1 | 23±2 |
| nPNA (g/kg) | 1.1±0.1 | 1.2±0.1 |
| Energy intake (kcal/kg) | 31±1 | 32±1 |
| SGA score | 7 (6–7) | 7 (6–7) |
| CRP (mg/l) | 3 (2–3) | 3 (2–5) |
| Estimated GFR (ml/min per 1.73 m2) | 109±6 | 17±1b |
| Blood glucose (mmol/l) | 4.0±0.1 | 4.3±0.1 |
| (HCO3) (mmol/l) | 24±1 | 19±1 |
| Albumin (g/dl) | 4.2±0.1 | 4.1±0.1 |
| Hemoglobin (g/dl) | 13.5±1 | 11.5±0.5a |
| BUN (mg/dl) | 20±2 | 88±4b |
Abbreviations: BMI, body mass index; BUN, blood urea nitrogen; CRP, C-reactive protein; F, female; FFM, fat-free mass; GFR, glomerular filtration rate; M, male; nPNA, normalized protein nitrogen appearance; SGA, Subjective Global Assessment.
Data are mean±s.e.m. or median (range). Significance of difference versus control subjects:
a
P<0.05;
b
P<0.01.